News & Events

The latest BrainSpec announcements, press releases, and media coverage.

meet us in person

Conferences

Connect with the BrainSpec team at upcoming industry events.

November 2026

SNO Annual Meeting

Philadelphia, PA

Nov – Dec 2026

RSNA Annual Meeting

Chicago, IL

Latest Updates

News & Press

Announcements, media coverage, and clinical milestones from BrainSpec and our research partners.

October 24, 2025

BrainSpec MRS Platform Demonstrates Value in Detecting Brain Abnormalities

Clinical study shows BrainSpec identified previously undetected brain injuries in 90% of participants with traumatic brain injury histories.

September 4, 2025

BrainSpec and University of Minnesota Collaborate to Advance Automation in MR Spectroscopy with AutoVOI

BrainSpec licenses AutoVOI, a patented technology from the University of Minnesota's Center for Magnetic Resonance Research (CMRR), that automates voxel placement in MR spectroscopy — removing a key barrier to clinical adoption.

April 5, 2024

BrainSpec, Lin: Virtual Biopsies

Feature article on BrainSpec's origin at Brigham & Women's Hospital, co-founder Alexander Lin's vision, and the path from concept to FDA-cleared product.

December 1, 2023

FDA Clears BrainSpec Tool to Measure Metabolites in Brain Scans

Multiple Sclerosis News Today covers the FDA clearance with emphasis on BrainSpec's applications for MS diagnosis and monitoring.

November 30, 2023

FDA Clears BrainSpec's AI-Powered MRS Platform

Additional coverage of BrainSpec's FDA clearance highlighting compatibility with GE, Siemens, and Philips scanners covering 77.4% of the MRI device market.

November 28, 2023

BrainSpec AI Software Receives FDA Clearance to Assist in Diagnosis of Neurologic Disorders

Practical Neurology covers BrainSpec's FDA clearance as the first AI software platform using a brain chemistry reference database.

November 27, 2023

BrainSpec Receives Full FDA Clearance for AI-Backed Non-Invasive Brain Chemistry Measurement

Official press release announcing FDA clearance with 85% sensitivity and 90% specificity for 2-HG detection. Potential to reduce healthcare costs by $98,000 per patient over five years.